Goldman Sachs Downgrades Bruker To Sell

Analysts at Goldman Sachs downgraded

from Buy to Sell. The price target for Bruker has been lowered from $21 to $15. Bruker shares have dropped 2.86% over the past 52 weeks, while the S&P 500 index has gained 11.23% in the same period. Bruker's shares fell 0.70% to $18.55 in pre-market trading.